6-53005156-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_014920.5(CILK1):c.1892G>A(p.Arg631Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,614,124 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R631P) has been classified as Uncertain significance.
Frequency
Consequence
NM_014920.5 missense
Scores
Clinical Significance
Conservation
Publications
- endocrine-cerebro-osteodysplasia syndromeInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
- juvenile myoclonic epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CILK1 | NM_014920.5 | c.1892G>A | p.Arg631Gln | missense_variant | Exon 14 of 14 | ENST00000676107.1 | NP_055735.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CILK1 | ENST00000676107.1 | c.1892G>A | p.Arg631Gln | missense_variant | Exon 14 of 14 | NM_014920.5 | ENSP00000501692.1 | |||
CILK1 | ENST00000350082.10 | c.1913G>A | p.Arg638Gln | missense_variant | Exon 14 of 14 | 1 | ENSP00000263043.8 | |||
CILK1 | ENST00000356971.3 | c.1892G>A | p.Arg631Gln | missense_variant | Exon 15 of 15 | 2 | ENSP00000349458.3 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152174Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000358 AC: 9AN: 251278 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461832Hom.: 1 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727228 show subpopulations
GnomAD4 genome AF: 0.000112 AC: 17AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74470 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:2
The c.1892G>A (p.R631Q) alteration is located in exon 15 (coding exon 13) of the ICK gene. This alteration results from a G to A substitution at nucleotide position 1892, causing the arginine (R) at amino acid position 631 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Variant summary: CILK1 c.1892G>A (p.Arg631Gln) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 3.5e-05 in 282672 control chromosomes, predominantly at a frequency of 0.0002 within the African or African-American subpopulation in the gnomAD database. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.1892G>A in individuals affected with CILK1-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at